Skip to main content

Research publications repository

    • čeština
    • English
  • English 
    • čeština
    • English
  • Login
View Item 
  •   CU Research Publications Repository
  • Fakulty
  • Faculty of Science
  • View Item
  • CU Research Publications Repository
  • Fakulty
  • Faculty of Science
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Vaccinia virus mRNAs containing long 5'-poly(A)-leaders lack a canonical 5'-methylguanosine cap

original article
Creative Commons License IconCreative Commons BY Icon
en
published version
  • no other version
Thumbnail
File can be accessed.Get publication
Author
Vopálenský, VáclavORCiD Profile - 0000-0002-4858-4645WoS Profile - Q-6418-2017Scopus Profile - 8575785500
Sýkora, MichalORCiD Profile - 0000-0001-8049-0748WoS Profile - P-4441-2017Scopus Profile - 57204520302
Mělková, ZoraORCiD Profile - 0000-0002-9709-2110WoS Profile - J-4209-2017Scopus Profile - 6603581712
Barvík, IvanORCiD Profile - 0000-0002-0802-1346WoS Profile - G-8906-2014Scopus Profile - 16634588600
Horáčková, KamilaORCiD Profile - 0009-0007-3868-0696WoS Profile - PFP-3713-2025Scopus Profile - 60249726500
Mašek, TomášORCiD Profile - 0000-0001-8732-0565WoS Profile - Q-4636-2017Scopus Profile - 6603131017
Pospíšek, MartinORCiD Profile - 0000-0002-9490-8911WoS Profile - A-9100-2008Scopus Profile - 6602708932

Show other authors

Publication date
2025
Published in
Nature Communications
Publisher / Publication place
Nature Publishing Group
Volume / Issue
16 (1)
ISBN / ISSN
ISSN: 2041-1723
ISBN / ISSN
eISSN: 2041-1723
Funding Information
MSM//LM2023055
MSM//LX22NPO5103
UK//COOP
Metadata
Show full item record
Collections
  • 1. Faculty of Medicine
  • Faculty of Mathematics and Physics
  • Faculty of Science

This publication has a published version with DOI 10.1038/s41467-025-67916-w

Abstract
The vaccinia virus (VACV) is a prototypical poxvirus that was originally used to eradicate smallpox. Half a century ago, investigation into VACV mRNA substantially contributed to the fundamental discovery of the 5' mRNA cap, a hallmark of all eukaryotic and many viral mRNAs. VACV research also facilitated the identification and understanding of the general mechanism of 5' mRNA cap synthesis. We analyzed VACV transcripts at the level of individual mRNA molecules using a modified 5' RACE method. Our results demonstrate that VACV mRNAs containing long nontemplated 5' poly(A) leaders lack the 5' cap structure in vivo. The probability of the m(7)G cap occurrence decreases with the increasing number of nontemplated adenosines in the 5' poly(A) leader. Although half of VACV mRNAs with a single nontemplated adenosine still contain the m(7)G cap, only about 4% of viral mRNAs with leaders consisting of six or more nontemplated adenosines retain the cap. Uncapped mRNA can be transcribed from all genes containing adenosine-rich initiator sequences (INR) within their promoters. Early genes with INR still produce mostly capped transcripts (40%-59%, depending on the gene). However, intermediate mRNAs are less capped (11%-56%) and late mRNAs are mostly uncapped (0%-10% of capped mRNAs, depending on the gene).
Keywords
vaccinia virus, mRNA, 5′ poly(A) leader, m7G cap, viral transcription
Permanent link
https://hdl.handle.net/20.500.14178/3406
Show publication in other systems
WOS:001644813400001
SCOPUS:2-s2.0-105025418701
PUBMED:41430051
License

Full text of this result is licensed under: Creative Commons Uveďte původ 4.0 International

Show license terms

xmlui.dri2xhtml.METS-1.0.item-publication-version-

DSpace software copyright © 2002-2016  DuraSpace
Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

About Repository

About This RepositoryResearch outputs typologyRequired metadataDisclaimerCC Linceses

Browse

All of DSpaceCommunities & CollectionsWorkplacesBy Issue DateAuthorsTitlesSubjectsThis CollectionWorkplacesBy Issue DateAuthorsTitlesSubjects

DSpace software copyright © 2002-2016  DuraSpace
Contact Us | Send Feedback
Theme by 
Atmire NV